Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board changes

30 May 2024 12:00

RNS Number : 4436Q
Xaar PLC
30 May 2024
Β 

30 May 2024

Β 

Xaar plc

Β 

Board changes

Β 

Xaar plc ("Xaar" or "the Group" or "the Company"), the leading inkjet printing technology group, is pleased to announce the appointment of Dr Inken Braunschmidt as Independent Non-Executive Director.

Β 

Inken joins the Board with effect from 1 June 2024 and on appointment will be a member of the Audit, Remuneration and Nomination Committees.

Β 

As previously disclosed, Alison Littley had notified the Board of her intention to step down as a Non-Executive Director of the Company during 2024. It is now confirmed that Alison will leave the Board on 30 June 2024. Inken will be appointed as Chair of Remuneration Committee on 1 July 2024.

Β 

Richard Amos, Non-Executive Director, will replace Alison Littley as the Company's Senior Independent Director on 1 July 2024.

Β 

Inken Braunschmidt is currently a non-executive director of James Fisher and Sons plc, listed on the London Stock Exchange, and Chair of its Remuneration Committee as well as a member of the Audit and Nomination Committees. She was Chief Innovation and Digital Officer and member of the Executive Board of Halma plc until 2023. Prior to joining Halma plc in 2017, Inken spent 13 years at RWE AG, the German energy giant, and its renewables subsidiary innogy SE, where she held various international leadership roles focusing on strategy, innovation, digital transformation and change management. Inken studied Business Administration, Innovation & Technology Management at Kiel University and did her PhD thesis in Technology Management. Inken is member of the Digital Programme Board of the Royal Academy of Engineering.

Β 

Β 

Andrew Herbert, Chairman, commented:

Β 

"We are delighted to welcome Inken to the Board and her expertise and experience in international electronic engineering and digital innovation and transformation are very relevant to the opportunities and challenges that face Xaar. I would like to thank Alison for her contribution and commitment to the Board of Xaar as a director since 2020 and wish her the very best for the future."

Β 

The Company confirms there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to the appointment of Inken Braunschmidt.

Β 

Enquiries:

Β 

Xaar plc

+44 (0) 1223 423 663Β 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

Β 

Teneo

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAURAWRSAUVORR
Date   Source Headline
27th Mar 20077:00 amRNSDirector/PDMR Shareholding
21st Mar 20077:00 amRNSHolding(s) in Company
20th Mar 20071:38 pmRNSHolding(s) in Company
19th Mar 20074:02 pmRNSHolding(s) in Company
15th Mar 200711:29 amRNSDividend Record Date Amendmnt
15th Mar 20077:01 amRNSFinal Results
6th Mar 20076:30 pmRNSHolding(s) in Company
15th Feb 20077:01 amRNSNotice of Final Results
14th Feb 20077:01 amRNSOffer Talks Terminated
12th Feb 20076:22 pmRNSHolding(s) in Company
9th Feb 200712:02 pmRNSEPT Disclosure
9th Feb 200710:14 amRNSRule 8.3- Xaar PLC
8th Feb 200711:53 amRNSRule 8.3- Xaar PLC
7th Feb 200711:20 amRNSEPT Disclosure
5th Feb 200710:56 amRNSEPT Disclosure
2nd Feb 200712:12 pmRNSEPT Disclosure
2nd Feb 200710:35 amRNSRule 8.3- Xaar PLC
31st Jan 200712:38 pmRNSRule 8.3- Xaar PLC
31st Jan 200712:02 pmRNSRule 8.3- Xaar PLC
30th Jan 20071:07 pmPRNRule 8.3 - XAAR PLC
30th Jan 200710:48 amRNSRule 8.3- Xaar PLC
29th Jan 20079:46 amRNSRule 8.3- Xaar PLC
25th Jan 200710:32 amRNSEPT Disclosure
25th Jan 200710:21 amRNSRule 8.3- Xaar PLC
24th Jan 200710:06 amRNSRule 8.3- Xaar PLC
23rd Jan 20079:19 amRNSRule 8.3- Xaar PLC
22nd Jan 200711:32 amRNSRule 8.3- Xaar PLC
19th Jan 20079:45 amRNSRule 8.3- Xaar
17th Jan 200711:54 amRNSEPT Disclosure
16th Jan 200711:48 amRNSEPT Disclosure
16th Jan 20079:52 amRNSRule 8.3- Xaar PLC
15th Jan 200711:01 amRNSRule 8.3- Xaar PLC
12th Jan 200710:30 amRNSEPT Disclosure
29th Dec 20069:20 amRNSAdditional Listing
28th Dec 200611:46 amRNSEPT Disclosure
28th Dec 20068:50 amRNSAdditional Listing
27th Dec 20069:03 amRNSAdditional Listing
22nd Dec 20068:32 amRNSAdditional Listing
21st Dec 200612:28 pmRNSEPT Disclosure
21st Dec 200610:30 amRNSAdditional Listing
21st Dec 200610:29 amRNSAdditional Listing
20th Dec 20064:22 pmRNSHolding(s) in Company
19th Dec 200612:21 pmRNSTotal Voting Rights
19th Dec 200612:02 pmRNSEPT Disclosure
18th Dec 20061:34 pmRNSEPT Disclosure
18th Dec 20061:07 pmRNSRule 8.3- Xaar PLC
15th Dec 200612:45 pmRNSEPT Disclosure
12th Dec 20061:02 pmRNSEPT Disclosure
11th Dec 200611:52 amPRNRule 8.3
8th Dec 200612:29 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.